RB1 and neoplasm: In contrast with the above findings, Patrick et al. demonstrated that simultaneous combination treatment of carboplatin with PD decreased antitumour activity compared with carboplatin treatment alone in Rb-proficient mice and that the coadministration of PD with carboplatin had no effect on tumour growth in vivo [28].